143 related articles for article (PubMed ID: 8315818)
1. Improvement of cardiac performance by pimobendan, a new cardiotonic drug, in the experimental failing dog heart.
Satoh K; Satoh Y; Imagawa J; Taira N
Jpn Heart J; 1993 Mar; 34(2):213-9. PubMed ID: 8315818
[TBL] [Abstract][Full Text] [Related]
2. Improvement of pentobarbital-induced heart failure by MCI-154, a novel and potent cardiotonic agent, in the dog heart-lung preparation.
Satoh K; Nunoki K; Goto T; Hosono M; Hashimoto H; Sato Y; Taira N
Jpn J Pharmacol; 1988 Jun; 47(2):189-95. PubMed ID: 3199595
[TBL] [Abstract][Full Text] [Related]
3. Improvement of cardiac performance by AR-L 115 BS, a new cardiotonic drug, in the experimental failing dog heart.
Morita T; Satoh K; Taira N
Jpn Heart J; 1984 May; 25(3):439-45. PubMed ID: 6088828
[TBL] [Abstract][Full Text] [Related]
4. Effect of pimobendan on the incidence of arrhythmias in small breed dogs with myxomatous mitral valve degeneration.
Lake-Bakaar GA; Singh MK; Kass PH; Griffiths LG
J Vet Cardiol; 2015 Jun; 17(2):120-8. PubMed ID: 26007710
[TBL] [Abstract][Full Text] [Related]
5. A multicenter, randomized, double-blind, placebo-controlled trial of pimobendan, a new cardiotonic and vasodilator agent, in patients with severe congestive heart failure.
Katz SD; Kubo SH; Jessup M; Brozena S; Troha JM; Wahl J; Cohn JN; Sonnenblick EH; LeJemtel TH
Am Heart J; 1992 Jan; 123(1):95-103. PubMed ID: 1729854
[TBL] [Abstract][Full Text] [Related]
6. Amelioration of heart failure by MDL 17043 and MDL 19205, novel positive inotropic drugs, in dog heart-lung preparations.
Goto T; Nunoki K; Satoh K; Taira N
Jpn Heart J; 1985 Nov; 26(6):1011-8. PubMed ID: 2937939
[TBL] [Abstract][Full Text] [Related]
7. Clinical efficacy and safety of pimobendan in treatment of heart failure--experience in Japan.
Kato K
Cardiology; 1997; 88 Suppl 2():28-36. PubMed ID: 9142433
[TBL] [Abstract][Full Text] [Related]
8. Effects of pimobendan on adverse cardiac events and physical activities in patients with mild to moderate chronic heart failure: the effects of pimobendan on chronic heart failure study (EPOCH study).
Effects of Pimobendan on Chronic Heart Failure Study (EPOCH Study)
Circ J; 2002 Feb; 66(2):149-57. PubMed ID: 11999639
[TBL] [Abstract][Full Text] [Related]
9. Positive chronotropic and inotropic effects of pimobendan (UD-CG 115 BS) in isolated, cross-circulated canine heart preparations.
Furukawa Y; Akahane K; Ogiwara Y; Haniuda M; Chiba S
Arch Int Pharmacodyn Ther; 1989; 300():159-73. PubMed ID: 2575887
[TBL] [Abstract][Full Text] [Related]
10. Effect of Pimobendan in Dogs with Preclinical Myxomatous Mitral Valve Disease and Cardiomegaly: The EPIC Study-A Randomized Clinical Trial.
Boswood A; Häggström J; Gordon SG; Wess G; Stepien RL; Oyama MA; Keene BW; Bonagura J; MacDonald KA; Patteson M; Smith S; Fox PR; Sanderson K; Woolley R; Szatmári V; Menaut P; Church WM; O'Sullivan ML; Jaudon JP; Kresken JG; Rush J; Barrett KA; Rosenthal SL; Saunders AB; Ljungvall I; Deinert M; Bomassi E; Estrada AH; Fernandez Del Palacio MJ; Moise NS; Abbott JA; Fujii Y; Spier A; Luethy MW; Santilli RA; Uechi M; Tidholm A; Watson P
J Vet Intern Med; 2016 Nov; 30(6):1765-1779. PubMed ID: 27678080
[TBL] [Abstract][Full Text] [Related]
11. Short-term hemodynamic and neuroendocrine effects of pimobendan and benazapril in dogs with myxomatous mitral valve disease and congestive heart failure.
Häggström J; Lord PF; Höglund K; Ljungvall I; Jöns O; Kvart C; Hansson K
J Vet Intern Med; 2013; 27(6):1452-62. PubMed ID: 24128373
[TBL] [Abstract][Full Text] [Related]
12. Use of pimobendan in the management of heart failure.
Fuentes VL
Vet Clin North Am Small Anim Pract; 2004 Sep; 34(5):1145-55. PubMed ID: 15325474
[TBL] [Abstract][Full Text] [Related]
13. Pimobendan and its use in treating canine congestive heart failure.
Bowles D; Fry D
Compend Contin Educ Vet; 2011 Nov; 33(11):E1. PubMed ID: 22101450
[TBL] [Abstract][Full Text] [Related]
14. Pimobendan in heart failure therapy--a silver bullet?
Gordon SG; Miller MW; Saunders AB
J Am Anim Hosp Assoc; 2006; 42(2):90-3. PubMed ID: 16527909
[TBL] [Abstract][Full Text] [Related]
15. Cardiac and coronary vasodilator profile of pimobendan, a new cardiotonic drug, revealed by use of isolated, blood-perfused dog heart preparations.
Imagawa J; Satoh K; Taira N
Heart Vessels; 1987; 3(4):182-9. PubMed ID: 3453824
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of pimobendan on survival and reoccurrence of pulmonary edema in canine congestive heart failure.
Mizuno M; Yamano S; Chimura S; Hirakawa A; Takusagawa Y; Sawada T; Maetani S; Takahashi A; Mizuno T; Harada K; Shinoda A; Uchida S; Takeuchi J; Mizukoshi T; Endo M; Uechi M
J Vet Med Sci; 2017 Jan; 79(1):29-34. PubMed ID: 27644192
[TBL] [Abstract][Full Text] [Related]
17. Effect of pimobendan on case fatality rate in Doberman Pinschers with congestive heart failure caused by dilated cardiomyopathy.
O'Grady MR; Minors SL; O'Sullivan ML; Horne R
J Vet Intern Med; 2008; 22(4):897-904. PubMed ID: 18537880
[TBL] [Abstract][Full Text] [Related]
18. Longitudinal Analysis of Quality of Life, Clinical, Radiographic, Echocardiographic, and Laboratory Variables in Dogs with Preclinical Myxomatous Mitral Valve Disease Receiving Pimobendan or Placebo: The EPIC Study.
Boswood A; Gordon SG; Häggström J; Wess G; Stepien RL; Oyama MA; Keene BW; Bonagura J; MacDonald KA; Patteson M; Smith S; Fox PR; Sanderson K; Woolley R; Szatmári V; Menaut P; Church WM; O'Sullivan ML; Jaudon JP; Kresken JG; Rush J; Barrett KA; Rosenthal SL; Saunders AB; Ljungvall I; Deinert M; Bomassi E; Estrada AH; Fernandez Del Palacio MJ; Moise NS; Abbott JA; Fujii Y; Spier A; Luethy MW; Santilli RA; Uechi M; Tidholm A; Schummer C; Watson P
J Vet Intern Med; 2018 Jan; 32(1):72-85. PubMed ID: 29214723
[TBL] [Abstract][Full Text] [Related]
19. Effect of pimobendan or benazepril hydrochloride on survival times in dogs with congestive heart failure caused by naturally occurring myxomatous mitral valve disease: the QUEST study.
Häggström J; Boswood A; O'Grady M; Jöns O; Smith S; Swift S; Borgarelli M; Gavaghan B; Kresken JG; Patteson M; Ablad B; Bussadori CM; Glaus T; Kovacević A; Rapp M; Santilli RA; Tidholm A; Eriksson A; Belanger MC; Deinert M; Little CJ; Kvart C; French A; Rønn-Landbo M; Wess G; Eggertsdottir AV; O'Sullivan ML; Schneider M; Lombard CW; Dukes-McEwan J; Willis R; Louvet A; DiFruscia R
J Vet Intern Med; 2008; 22(5):1124-35. PubMed ID: 18638016
[TBL] [Abstract][Full Text] [Related]
20. Longitudinal analysis of quality of life, clinical, radiographic, echocardiographic, and laboratory variables in dogs with myxomatous mitral valve disease receiving pimobendan or benazepril: the QUEST study.
Häggström J; Boswood A; O'Grady M; Jöns O; Smith S; Swift S; Borgarelli M; Gavaghan B; Kresken JG; Patteson M; Åblad B; Bussadori CM; Glaus T; Kovačević A; Rapp M; Santilli RA; Tidholm A; Eriksson A; Belanger MC; Deinert M; Little CJ; Kvart C; French A; Rønn-Landbo M; Wess G; Eggertsdottir A; Lynne O'Sullivan M; Schneider M; Lombard CW; Dukes-McEwan J; Willis R; Louvet A; DiFruscia R
J Vet Intern Med; 2013; 27(6):1441-51. PubMed ID: 24010489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
